Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1999
10/06/1999EP0947194A1 Dosage form comprising solid salts of R-alpha-lipoic acid with improved bioavailability
10/06/1999EP0947193A2 Percutaneously applicable preparation and suppository containing an antidementia medicament
10/06/1999EP0947192A1 Transparent antidandruff shampoos
10/06/1999EP0946869A1 Channel mediating substrates
10/06/1999EP0946733A1 Hsv/aav hybrid amplicon vectors
10/06/1999EP0946724A2 POLYPEPTIDES OF THE "BASIC-HELIX-LOOP-HELIX" bHLH FAMILY, CORRESPONDING NUCLEIC ACID SEQUENCES
10/06/1999EP0946721A1 Human growth gene and short stature gene region
10/06/1999EP0946587A2 New amide compounds
10/06/1999EP0946586A1 Aminosterol ester compounds
10/06/1999EP0946585A1 Steroids substituted in position 11, method of preparation, application as medicines and pharmaceutical compositions containing them
10/06/1999EP0946584A1 Meiosis regulating compounds
10/06/1999EP0946580A1 Novel erythromycin derivatives, method of preparation and application as medicines
10/06/1999EP0946579A1 Novel erythromycin derivatives, method for preparing them and their use as medicine
10/06/1999EP0946568A1 Use of 7-alkylidene cephalosporins to inhibit elastase activity
10/06/1999EP0946567A1 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
10/06/1999EP0946566A1 Pro-drugs and counterparts of camptothecin, their application as medicines
10/06/1999EP0946564A1 New process for the preparation of morphinans
10/06/1999EP0946562A1 PYRROLO 3,4-$i(D)]PYRIMIDINONE DERIVATIVES AND THEIR USE AS MEDICAMENTS
10/06/1999EP0946561A1 Triazolo(4,5-d)pyrimidinyl derivatives and their use as medicaments
10/06/1999EP0946558A1 Ethylidene derivatives of tricyclic carbapenems
10/06/1999EP0946557A1 A-1-adenosine receptor antagonists
10/06/1999EP0946555A1 Pyrrole derivatives, their preparation and pharmaceutical compositions containing them
10/06/1999EP0946554A1 Fused bicyclic pyrimidine derivatives
10/06/1999EP0946552A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/06/1999EP0946551A2 N-piperazin-1-ylphenyl-benzamide derivatives
10/06/1999EP0946548A1 Novel heterocyclic substituted pyrrolidine amide derivatives
10/06/1999EP0946547A1 A novel compound form
10/06/1999EP0946546A1 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
10/06/1999EP0946545A1 Novel carboxy substituted cyclic carboxamide derivatives
10/06/1999EP0946542A1 Indane or dihydroindole derivatives
10/06/1999EP0946541A1 Quinolines and their therapeutic use
10/06/1999EP0946539A1 Sulphonamide derivatives, process for their preparation, and their use as medicaments
10/06/1999EP0946538A1 Indane or dihydroindole derivatives
10/06/1999EP0946528A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
10/06/1999EP0946524A1 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists
10/06/1999EP0946523A1 Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
10/06/1999EP0946520A1 Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors
10/06/1999EP0946519A1 Benzamide derivatives having a vasopressin antagonistic activity
10/06/1999EP0946518A1 Modulators of proteins with phosphotyrosine recognition units
10/06/1999EP0946517A1 N-(imidazolylbutyl) benzenesulphonamide derivatives, their preparation and therapeutic application
10/06/1999EP0946515A1 Parasiticidal pyrazoles
10/06/1999EP0946512A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/06/1999EP0946511A1 Novel compounds with analgesic effect
10/06/1999EP0946510A1 Novel compounds with analgesic effect
10/06/1999EP0946509A1 Novel heterocyclically substituted benzamides and their use in fighting diseases
10/06/1999EP0946508A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS
10/06/1999EP0946503A1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase
10/06/1999EP0946502A1 Sulfonamide interleukin-beta converting enzyme inhibitors
10/06/1999EP0946501A1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
10/06/1999EP0946499A1 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
10/06/1999EP0946497A1 Process for the preparation of nmda antagonists
10/06/1999EP0946495A1 Phenyl acetamides as spla2 inhibitors
10/06/1999EP0946485A2 Method for treatment of dermatological disorders
10/06/1999EP0946221A1 Combatting infection in delivery systems
10/06/1999EP0946201A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
10/06/1999EP0946199A1 TGF beta 1-RESPONSIVE CELLS FROM BONE MARROW
10/06/1999EP0946197A1 Lubricious self-standing (intact) gel for oral delivery of biologically-active ingredients
10/06/1999EP0946190A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
10/06/1999EP0946188A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
10/06/1999EP0946185A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
10/06/1999EP0946184A2 Novel formulations for the administration of fluoxetine
10/06/1999EP0946183A1 Methods of treating or preventing cardiac arrhythmia
10/06/1999EP0946182A1 17$g(a)-DIHYDROEQUILENIN FOR USE AS A MEDICAL ANTIOXIDANT
10/06/1999EP0946181A1 Use of 2-(2-morpholinophenyl) guanidine derivatives for the treatment of diabetes complications
10/06/1999EP0946180A1 Method for stimulating bone formation
10/06/1999EP0946179A1 Method for treating autism
10/06/1999EP0946178A1 Combination therapy for reducing the risks associated with cardiovascular disease
10/06/1999EP0946177A1 METHOD OF INHIBITING BIOSYNTHESIS OF EIf5A
10/06/1999EP0946176A1 The use of 7-(2-oxa-5,8-diazabicyclo 4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of helicobacter pylori infections and associated gastroduodenal diseases
10/06/1999EP0946175A1 USE OF AN H+, K+ -ATPase INHIBITOR IN THE TREATMENT OF NASAL POLYPS
10/06/1999EP0946174A1 Treatment of urinary incontinence and compositions for use therein
10/06/1999EP0946173A1 Preparation of 3-fluoro oxindole derivatives
10/06/1999EP0946172A1 Method for inhibiting stress-activated protein kinases
10/06/1999EP0946171A1 Ophtalmic viscoelastic compositions
10/06/1999EP0946170A1 Inhibition of protein glycation and prevention of vasculopathy
10/06/1999EP0946168A1 Use of ethylene diamine disuccinate for preparing a medicament with antiviral properties
10/06/1999EP0946167A1 Use of an osmolyte in the preparation of a medicament for treating complications resulting from ischemia
10/06/1999EP0946166A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
10/06/1999EP0946165A1 Integrin antagonists
10/06/1999EP0946164A1 Integrin antagonists
10/06/1999EP0946163A2 Salts of acetaminophen
10/06/1999EP0946162A1 Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases
10/06/1999EP0946161A1 Sustained release pharmaceutical tablets with tramadol base and their preparation
10/06/1999EP0946160A1 Lipophilic polyamine esters for the site specific delivery of nitric oxide in pharmaceutical use
10/06/1999EP0946159A1 An oil composition of dihydropolyprenols
10/06/1999EP0946157A2 The topical use of kappa opioid agonists to treat ocular pain
10/06/1999EP0946156A2 Therapeutic agents
10/06/1999EP0946155A1 Pharmaceutical composition for treating fecal incontinence and anal itch
10/06/1999EP0946151A1 Ascending-dose dosage form
10/06/1999EP0946149A1 Homogeneous preformulations containing wigh concentrations of steroids, for producing low-dose solid and semi-solid pharmaceutical preparations
10/06/1999EP0946148A2 Non-ionic surfactant vesicles as a delivery agent for nucleic acid
10/06/1999EP0946147A1 Treatment of equine laminitis
10/06/1999EP0946146A2 New aqueous medicament preparations for the production of propellent gas-free aerosols
10/06/1999EP0946145A2 Antitussive drugs delivered by ion exchange resins
10/06/1999EP0946143A2 A nitroimidazole gel composition
10/06/1999EP0946139A1 Pharmaceutical formulation
10/06/1999EP0946099A1 Endoparasiticidal and ectoparasiticidal agents
10/06/1999EP0946096A1 Nefazodone: use in treating post traumatic stress disorder
10/06/1999EP0866693A4 Topically applied, structural cellulite treatments
10/06/1999EP0839133B1 4,9-ethano-benzo(f)isoindole derivatives as farnesyl transferase inhibitors